(Q44366717)

English

Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients

scientific article published in March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Ben-Ari Z

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mor E

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Bar-Nathan N

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Shaharabani E

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Shapira Z

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Tur-Kaspa R

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

609-611

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900008-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900008-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900008-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900008-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900008-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900008-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900008-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900008-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900008-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900008-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900008-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0041-1345(03)00008-3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44366717&oldid=2020148212"